Sotera Health Co (SHC)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $4.74B
Last updated: Nov 17, 2026 at 11:06 AM ET
Sotera Health Co (SHC) Stock Forecast
Analysts expect Sotera Health (SHC) to earn $0.98 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.24B. Of 10 analysts, 8 rate the stock Buy or Strong Buy, 1 Hold and 1 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 10 ratings average 2.10, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 80% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 30.0% |
| Buy | 5 | 50.0% |
| Hold | 1 | 10.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 10.0% |
- Consensus
- Buy
- Total analysts
- 10
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 9.2% and revenue estimates rise 5.6%.
- Fiscal year ending Dec 31, 2026
- $0.98
- EPS consensus, revenue $1.24B
- Fiscal year ending Dec 31, 2027
- $1.07
- EPS consensus, revenue $1.31B
- Next report
- Feb 22, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.98 | $0.98 to $1.00 | 10 | $1.24B | $1.24B to $1.25B | 9 |
| Dec 31, 2027 | $1.07 | $1.03 to $1.13 | 10 | $1.31B | $1.31B to $1.32B | 9 |
Quarterly Estimates
The EPS consensus falls from $0.26 for the quarter ending Dec 31, 2026 to $0.20 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.26 | $0.25 to $0.28 | 11 | $321.41M | $308.70M to $341.04M | 11 |
| Mar 31, 2027 | $0.20 | $0.18 to $0.22 | 8 | $294.32M | $292.67M to $296.33M | 6 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 3 upward and 6 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 1 |
| Fiscal year ending Dec 31, 2027 | 1 | 5 |
EPS Trend
The EPS consensus for the fiscal year ending Dec 31, 2026 has held over the last 90 days.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.98 | $0.98 | $0.98 | $0.98 | $0.98 | -0.2% |
| Fiscal year ending Dec 31, 2027 | $1.07 | $1.08 | $1.08 | $1.07 | $1.07 | -0.9% |
| Quarter ending Mar 31, 2027 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | +1.1% |
Frequently Asked Questions About SHC
What is the SHC stock forecast?
Consensus analyst estimates put Sotera Health's EPS at $0.98 for the fiscal year ending Dec 31, 2026, on revenue of $1.24B. The consensus rating from 10 analysts is Buy.
How do analysts rate SHC stock?
Of 10 analysts covering Sotera Health, 3 rate it Strong Buy, 5 Buy, 1 Hold, 0 Sell and 1 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from SHC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.98, with estimates from $0.98 to $1.00 from 10 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.07, with estimates from $1.03 to $1.13 from 10 analysts.
What revenue do analysts expect from Sotera Health next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.24B, with estimates from $1.24B to $1.25B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.31B, with estimates from $1.31B to $1.32B.
How many analysts cover SHC?
10 analysts rate Sotera Health stock, and 10 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
SHC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors